Anti-inflammatory drug may shorten coronavirus recovery time: Study
4 years, 3 months ago

Anti-inflammatory drug may shorten coronavirus recovery time: Study

India Today  

A drug company says that adding an anti-inflammatory medicine to a drug already widely used for hospitalised Covid-19 patients shortens their time to recovery by an additional day. Eli Lilly announced the results Monday from a 1,000-person study The study tested baricitinib, a pill that Indianapolis-based Lilly already sells as Olumiant to treat rheumatoid arthritis, the less common form of arthritis that occurs when a mistaken or overreacting immune system attacks joints, causing inflammation. All study participants received remdesivir, a Gilead Sciences drug previously shown to reduce the time to recovery, defined as being well enough to leave the hospital, by four days on average. It would be important to know how many study participants also received steroid drugs, which have been shown in other research to lower the risk of death for severely ill, hospitalised Covid-19 patients, said Dr Jesse Goodman, former US Food and Drug Administration chief scientist now at Georgetown University who had no role in the study.

Drug Study Lilly Coronavirus Recovery  baricitinib  remdesivir  drug  study  hospitalised  shorten  system  shown  lilly  covid19  antiinflammatory  coronavirus  recovery

History of this topic

Remdesivir Could Reduce Covid Mortality if Given Early : Study
2 years, 1 month ago

Remdesivir Could Reduce Covid Mortality if Given Early : Study

News 18  

Remdesivir can reduce mortality in patients if administered within 9 days of COVID-19 symptom onset, according to a study conducted in Asian patients. Researchers from Tokyo Medical and Dental University have found that treatment with remdesivir within 9 days of COVID-19 symptom onset decreases mortality in Asian patients also taking corticosteroids, the study said. “In-hospital mortality rates were significantly lower …

Health Matters: Don't Feel Guilty About Not Finding Remdesivir for Your Loved One. It Hardly Works
2 years, 11 months ago

Health Matters: Don't Feel Guilty About Not Finding Remdesivir for Your Loved One. It Hardly Works

News 18  

It was dinner time when she called for help. They don’t want to use it, but keep it.” Much before the outbreak of second wave, in November 2020, the World Health Organization issued a conditional recommendation against the use of Remdesivir in hospitalised patients, regardless of disease severity saying “there is currently no evidence that Remdesivir improves survival and other …

New COVID-19 treatment rules: India cuts down use of Remdesivir, Tocilizumab, multivitamins, steroids
2 years, 11 months ago

New COVID-19 treatment rules: India cuts down use of Remdesivir, Tocilizumab, multivitamins, steroids

Firstpost  

According to the new guidelines, Remdesivir may be considered only in patients who have completed 10 days since the start of the symptoms and require supplemental oxygen. While it states that doctors can “consider Remdesivir for five days to treat hospitalised patients with COVID-19”, it also mentions that “no evidence of benefit for treatment more than five days”. Discouraging the …

India Cuts Use of Remdesivir, Tocilizumab, Multivitamins, Steroids in Covid-19 Treatment
2 years, 11 months ago

India Cuts Use of Remdesivir, Tocilizumab, Multivitamins, Steroids in Covid-19 Treatment

News 18  

India has cut down on the use of the experimental drug Remdesivir and immunosuppressive drug Tocilizumab for the treatment of Covid-19. While it states that doctors can “consider Remdesivir for five days to treat hospitalised patients with Covid-19”, it also mentions that “no evidence of benefit for treatment more than five days”. Discouraging the overuse of steroids, the protocol for …

COVID-19 Treatment: Cipla to manufacture and sell Eli Lilly's baricitinib in India
3 years, 8 months ago

COVID-19 Treatment: Cipla to manufacture and sell Eli Lilly's baricitinib in India

News 18  

Cipla on Monday announced that it has signed an agreement with Eli Lilly and Company to manufacture baricitinib for COVID-19 treatment. Baricitinib earlier received restricted emergency use approval by y the Central Drugs Standard Control Organization for use in combination with remdesivir for the treatment of hospitalized COVID-19 adult patients requiring supplemental oxygen, Cipla said. “We hope that our donations …

Centre issues updated clinical guidance for management of COVID-19 patients
3 years, 8 months ago

Centre issues updated clinical guidance for management of COVID-19 patients

The Hindu  

The Union Health Ministry has issued an updated ‘Clinical Guidance for Management of Adult COVID-19 Patients’ recommending emergency use authorisation of remdesivir for patients with moderate to severe diseases, requiring supplemental oxygen, within 10 days of onset of symptoms. The guidelines issued by AIIMS, ICMR-COVID-19 National Task Force and the Joint Monitoring Group under the ministry stated that tocilizumab may …

'Not a Life-Saving Drug': ICMR Suggests Safe Use of Remdesivir in Covid-19
3 years, 8 months ago

'Not a Life-Saving Drug': ICMR Suggests Safe Use of Remdesivir in Covid-19

News 18  

The Indian Council of Medical Research on Tuesday shared some suggestions for rational and safe use of Remdesivir in Covid-19 as the demand for the medicine has increased for treating coronavirus patients especially in Covid-hit states including Maharashtra, Delhi, Karnataka and others. Remdesivir is one of the investigational drugs approved for emergency use in treating hospitalized Covid-19 patients. Suggestion for …

Trial comprising single Covid patient with genetic disorder shows remdesivir's benefits: Study
4 years ago

Trial comprising single Covid patient with genetic disorder shows remdesivir's benefits: Study

India Today  

Gilead's antiviral drug remdesivir could be highly effective against coronavirus, a study conducted by British scientists has found. The study, published in the journal Nature Communications involved a single Covid-19 patient with XLA, a rare genetic disorder. Nicholas Matheso, a co-author of the study, told news agency Reuters, "Our patient's unusual condition gave us a rare insight into the effectiveness …

FDA Grants Emergency Authorization For A 2nd COVID-19 Antibody Treatment
4 years, 1 month ago

FDA Grants Emergency Authorization For A 2nd COVID-19 Antibody Treatment

NPR  

FDA Grants Emergency Authorization For A 2nd COVID-19 Antibody Treatment Enlarge this image toggle caption Susan Walsh/AP Susan Walsh/AP One of the experimental drugs that President Trump received while he was battling the coronavirus has been approved for emergency use by the Food and Drug Administration. The drug, made by the biotech company Regeneron, is the second antibody treatment to …

Coronavirus pandemic: WHO advises doctors not to use Gilead’s Remdesivir for Covid-19 treatment
4 years, 1 month ago

Coronavirus pandemic: WHO advises doctors not to use Gilead’s Remdesivir for Covid-19 treatment

Hindustan Times  

The World Health Organization recommended against using Gilead Sciences Inc.’s remdesivir to treat hospitalized Covid-19 patients less than a month after U.S. regulators granted the drug a speedy approval. “But personally, our view in our industry is to use the better controlled studies to evaluate the benefits of medicines.” ‘Relatively High Cost’ The FDA originally granted emergency use authorization to …

FDA allows emergency use of antibody drug Trump received
4 years, 1 month ago

FDA allows emergency use of antibody drug Trump received

LA Times  

In an image from video, scientists work with a bioreactor at a Regeneron Pharmaceuticals facility in New York. U.S. health officials Saturday agreed to allow emergency use of a second antibody drug to help the immune system fight COVID-19, an experimental medicine that President Trump was given when he was sickened last month. The Food and Drug Administration authorized use …

WHO Suspends Remdesivir from List of COVID-19 Treatment Medicines
4 years, 1 month ago

WHO Suspends Remdesivir from List of COVID-19 Treatment Medicines

The Quint  

In July, Gilead priced Remdesivir at $2,340 for a five-day treatment in the US and some other developed countries, reported Al Jazeera. The WHO panel said, however, that it supported continued enrolment into clinical trials evaluating Remdesivir in patients with COVID-19, which it said should “provide higher certainty of evidence for specific groups of patients”. The WHO’s recommendation is not …

Health experts clash over use of certain drugs for COVID-19
4 years, 1 month ago

Health experts clash over use of certain drugs for COVID-19

Associated Press  

Health officials around the world are clashing over the use of certain drugs for COVID-19, leading to different treatment options for patients depending on where they live. On Friday, a World Health Organization guidelines panel advised against using the antiviral remdesivir for hospitalized patients, saying there’s no evidence it improves survival or avoids the need for breathing machines. Within the …

WHO advises against use of Remdesivir to treat COVID-19, says drug has no 'important effect' to reduce deaths
4 years, 1 month ago

WHO advises against use of Remdesivir to treat COVID-19, says drug has no 'important effect' to reduce deaths

Firstpost  

A WHO Guideline Development Group of international experts said there was ’no evidence based on currently available data that the anti-viral drug does improve patient-important outcomes' Paris: The anti-viral drug remdesivir should not be used to treat COVID-19 patients no matter how severe their illness as it has “no important effect” on survival chances, the World Health Organization said Friday. …

WHO advises against use of remdesivir for treating COVID-19
4 years, 1 month ago

WHO advises against use of remdesivir for treating COVID-19

Al Jazeera  

Global health agency says there is no evidence that drug improves survival rates or reduces need for ventilation. A World Health Organization expert panel has advised against the use of the antiviral drug remdesivir for patients admitted to hospital with COVID-19, regardless of how severely ill they are, because there is currently no evidence that it improves survival or the …

WHO suspends remdesivir from list of medicines after warning against use on Covid-19 patients
4 years, 1 month ago

WHO suspends remdesivir from list of medicines after warning against use on Covid-19 patients

India Today  

The World Health Organisation has suspended Gilead’s remdesivir, the popular antiviral medicine that was initially being touted as a potential treatment for Covid-19 cases for months, from its list of medicines. According to Reuters, WHO said on Friday it has suspended Gilead's remdesivir from its so-called prequalification list, an official list of medicines used as a benchmark for procurement by …

Coronavirus | U.S. gives full approval to antiviral remdesivir to treat COVID-19
4 years, 2 months ago

Coronavirus | U.S. gives full approval to antiviral remdesivir to treat COVID-19

The Hindu  

The U.S. Food and Drug Administration on Thursday granted full approval to the antiviral drug remdesivir as a treatment for patients hospitalized with COVID-19, after conditional authorization was given in May. However, other treatments have received authorization for emergency use, though that approval can be revoked once the public health emergency sparked by the coronavirus pandemic is over. “The FDA …

Antiviral Remdesivir: US Approves First Drug to Treat Covid-19, Cuts Recovery Period by 5 Days
4 years, 2 months ago

Antiviral Remdesivir: US Approves First Drug to Treat Covid-19, Cuts Recovery Period by 5 Days

News 18  

U.S. regulators on Thursday approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given through an IV for patients needing hospitalisation. The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days from 15 days to 10 on average in a large study led by the U.S. National Institutes of Health. …

WHO trial results show remdesivir has little or no effect for covid-19 patients
4 years, 2 months ago

WHO trial results show remdesivir has little or no effect for covid-19 patients

Live Mint  

Interim results from the World Health Organization’s solidarity trial showed that Gilead Sciences Inc’s remdesivir showed little or no effect for covid-19 patients, a result which was significantly different from the positive results shown by Gilead’s own trial. “These remdesivir, hydroxychloroquine, lopinavir and interferon regimens appeared to have little or no effect on hospitalized covid-19 patients, as indicated by overall …

WHO trial finds remdesivir has little effect on COVID-19
4 years, 2 months ago

WHO trial finds remdesivir has little effect on COVID-19

Al Jazeera  

Early results from large, randomised trial suggest antiviral does little to reduce mortality rates or time in hospital. A World Health Organization trial using four drugs including the antiviral remdesivir in the hospital treatment of COVID-19 has found the repurposed medicines have little to no effect on the length of time patients spend in hospital or their survival. “These Remdesivir, …

WHO: Study finds four drugs that have little to no effect on coronavirus, including remdesivir
4 years, 2 months ago

WHO: Study finds four drugs that have little to no effect on coronavirus, including remdesivir

India Today  

The World Health Organisation announced Friday the long-awaited results of its six-month “Solidarity Therapeutics Trial” that endeavored to see if existing drugs might have an effect on the coronavirus. What the study found The study, which was not peer-reviewed, found that four treatments tested - remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon - had “ little or no effect" on whether or …

Drug shows promise in 1st largely minority COVID-19 study
4 years, 3 months ago

Drug shows promise in 1st largely minority COVID-19 study

Associated Press  

A drug company said Friday that a medicine it sells to tamp down inflammation has helped prevent the need for breathing machines in hospitalized COVID-19 patients in the first large study that primarily enrolled Hispanics and Blacks. It’s unclear how the results will be viewed; another drug that works in a similar way failed in an experiment rigorously testing it …

US hospitals turn down remdesivir, limit use to sickest coronavirus patients
4 years, 3 months ago

US hospitals turn down remdesivir, limit use to sickest coronavirus patients

India Today  

US hospitals have turned down about a third of their allocated supplies of the Covid-19 drug remdesivir since July as need for the costly antiviral wanes, the Department of Health and Human Services confirmed on Friday. The Food and Drug Administration has allowed more liberal remdesivir use, but 6 out of 8 major hospital systems contacted by Reuters said they …

FDA approves expanded emergency use of remdesivir in moderate COVID-19 patients
4 years, 4 months ago

FDA approves expanded emergency use of remdesivir in moderate COVID-19 patients

The Hindu  

Gilead Inc said on Friday the U.S. Food and Drug Administration expanded the emergency use authorization of its experimental antiviral COVID-19 treatment, remdesivir, to allow its use in all hospitalized COVID-19 patients. The drug was authorized in May for use in patients with a severe form of the illness, after trial data showed the antiviral drug helped shorten hospital recovery …

Gilead says remdesivir reduced risk of death in coronavirus patients, more studies needed
4 years, 6 months ago

Gilead says remdesivir reduced risk of death in coronavirus patients, more studies needed

India Today  

Gilead Sciences Inc said on Friday additional data from a late-stage study showed its antiviral remdesivir reduced the risk of death and significantly improved the conditions of severely ill COVID-19 patients. Gilead said it analyzed data from 312 patients treated in a late-stage study and a separate real-world retrospective cohort of 818 patients with similar characteristics and disease severity as …

COVID-19 Treatment: Gilead to start testing inhalable form of remdesivir in 60 non-hospitalised patients
4 years, 6 months ago

COVID-19 Treatment: Gilead to start testing inhalable form of remdesivir in 60 non-hospitalised patients

Firstpost  

With inhaled remdesivir, Gilead is hoping to target the disease at the onset by delivering the drug directly to the primary site of infection. Gilead Sciences Inc said on Wednesday it has started an early-stage study of its antiviral COVID-19 treatment remdesivir that can be inhaled, for use outside of hospitals. The drug is currently used intravenously and an inhaled …

COVID-19 RECOVERY trial: HIV medicine found ineffective in treating hospitalised COVID-19 patients
4 years, 6 months ago

COVID-19 RECOVERY trial: HIV medicine found ineffective in treating hospitalised COVID-19 patients

Firstpost  

The HIV combination treatment lopinavir-ritonavir is also being studied in a trial by the World Health Organization. A combination of antiviral drugs used to treat HIV had no beneficial effect in patients hospitalised with COVID-19 in a large-scale randomised trial, British scientists said on Monday. Scientists running the RECOVERY trial at the University of Oxford said that the results “convincingly …

Dutch approve anti-viral medication for Covid-19 treatment
4 years, 6 months ago

Dutch approve anti-viral medication for Covid-19 treatment

NL Times  

Anti-viral medication remdesivir was approved for the treatment of patients with Covid-19, the Dutch Medicines Evaluation Board announced on Thursday. These patients recover on average four days earlier by treatment with remdesivir," the Dutch authority said. The MEB said there is no evidence yet showing that the drug can also help patients with a mild case of Covid-19. Covid-19 decrease …

Coronavirus pandemic: India approves emergency use of remdesivir to treat COVID-19 patients
4 years, 7 months ago

Coronavirus pandemic: India approves emergency use of remdesivir to treat COVID-19 patients

Hindustan Times  

India’s government said on Tuesday it has approved Gilead Sciences Inc’s antiviral drug remdesivir for emergency use for five doses in treating COVID-19 patients. The drug was granted emergency use authorization by the U.S. Food and Drug Administration last month and has received approval by Japanese health regulators. “ approved on June 1 under emergency use with condition for five …

Here’s how remdesivir improves time to recovery in Covid-19 patients
4 years, 7 months ago

Here’s how remdesivir improves time to recovery in Covid-19 patients

Hindustan Times  

Remdesivir, the antiviral under clinical trials for treatment against novel coronavirus infection, is superior to the standard of care given to COVID-19 patients, according to a new study. “Preliminary results of this trial suggest that a 10-day course of remdesivir was superior to placebo in the treatment of hospitalised patients with COVID-19,” the scientists wrote in the study. The study …

Remdesivir improves time to recovery in COVID-19 patients: Study
4 years, 7 months ago

Remdesivir improves time to recovery in COVID-19 patients: Study

India TV News  

Remdesivir, the antiviral under clinical trials for treatment against novel coronavirus infection, is superior to the standard of care given to COVID-19 patients, according to a new study. "Preliminary results of this trial suggest that a 10-day course of remdesivir was superior to placebo in the treatment of hospitalised patients with COVID-19," the scientists wrote in the study. The study …

Remdesivir preliminary results from NIAID trial published; suggest improvement in recovery time from COVID-19
4 years, 7 months ago

Remdesivir preliminary results from NIAID trial published; suggest improvement in recovery time from COVID-19

Firstpost  

As per the study, the mortality rate by day 14 was 7.1% in the remdesivir group as compared to 11.9% in the placebo group. These 8 points were: Not hospitalised and no limitation of any activity Not hospitalised, limitation of activity and need for home oxygen therapy Hospitalised but not requiring any additional medical care or oxygen therapy Hospitalised with …

Anti-viral drug remdesivir is effective: Study
4 years, 7 months ago

Anti-viral drug remdesivir is effective: Study

The Hindu  

Anti-viral drug remdesivir cuts recovery times in coronavirus patients, according to the full results of a trial published on Friday night, three weeks after America’s top infectious diseases expert said the study showed the medication has “clear-cut” benefits. Remdesivir shows 'clear-cut' effect in treating COVID-19 The study found that remdesivir, injected intravenously daily for 10 days, accelerated the recovery of …

Coronavirus | U.K. trial to test efficacy of five drugs
4 years, 7 months ago

Coronavirus | U.K. trial to test efficacy of five drugs

The Hindu  

With a range of approved drugs now being tested on COVID-19 patients, there is no clarity on which one will turn out to be more effective in treatment compared with the standard of hospital care that all patients receive. The recovery trial, coordinated by the Nuffield Department of Population Health at University of Oxford, will randomise patients to receive either …

US Food and Drug Administration allows emergency use of intravenous drug Remdesivir for patients hospitalised with COVID-19
4 years, 8 months ago

US Food and Drug Administration allows emergency use of intravenous drug Remdesivir for patients hospitalised with COVID-19

Firstpost  

The Food and Drug Administration cleared Gilead Science’s Remdesivir for hospitalised patients with “severe disease,” such as those experiencing breathing problems requiring supplemental oxygen or ventilators. As per the letter sent from the FDA to Gildead approving the Emergency Use Authorisation, “On February 4, 2020, pursuant to Section 564 of the Act, the Secretary of the Department of Health and …

US FDA approves Gilead's remdesivir to treat COVID-19 patients
4 years, 8 months ago

US FDA approves Gilead's remdesivir to treat COVID-19 patients

India TV News  

The Food and Drug Administration on Friday allowed the emergency use of Gilead's remdesivir that appears to help some COVID-19 patients recover faster, a milestone in the global search for effective therapies against the coronavirus. The regulator cleared Gilead Science’s intravenous drug for hospitalized patients with “severe disease,” such as those experiencing breathing problems requiring supplemental oxygen or ventilators. “As …

Remdesivir shows ‘clear-cut’ effect in treating COVID-19
4 years, 8 months ago

Remdesivir shows ‘clear-cut’ effect in treating COVID-19

The Hindu  

COVID-19 patients who took the antiviral remdesivir recovered about 30% faster than those on a placebo, the results of a major clinical trial showed on Wednesday, as the top U.S. epidemiologist hailed the drug’s “clear-cut” benefit. The U.S. National Institute of Allergy and Infectious Diseases, which oversaw the trial, said that patients on the drug made by Gilead Sciences had …

Remdesivir drug shows 'clear-cut' effect in treating coronavirus, says U.S.
4 years, 8 months ago

Remdesivir drug shows 'clear-cut' effect in treating coronavirus, says U.S.

The Hindu  

COVID-19 patients who took the antiviral remdesivir recovered about 30 percent faster than those on a placebo, the results of a major clinical trial showed Wednesday, as the top U.S. epidemiologist hailed the drug's “clear-cut” benefit. For Anthony Fauci, who leads the NIAID and has been one of the government's point people during the crisis, “the data shows that remdesivir …

Donald Trump is touting a new coronavirus drug. Here's what you need to know about remdesivir
4 years, 8 months ago

Donald Trump is touting a new coronavirus drug. Here's what you need to know about remdesivir

ABC  

An experimental antiviral drug is the latest coronavirus treatment being touted by the Donald Trump White House. The data also suggested a possible survival benefit with remdesivir, although the difference was not statistically significant, meaning it might have been due to chance and not Gilead's drug. Gilead Chief Medical Officer Merdad Parsey said in a statement that a five-day regimen, …

A 1st: US study finds Gilead drug works against coronavirus
4 years, 8 months ago

A 1st: US study finds Gilead drug works against coronavirus

Associated Press  

For the first time, a major study suggests that an experimental drug works against the new coronavirus, and U.S. government officials said Wednesday that they would work to make it available to appropriate patients as quickly as possible. In a study of 1,063 patients sick enough to be hospitalized, Gilead Sciences’s remdesivir shortened the time to recovery by 31% — …

Gilead's anti-viral drug Remdesivir succeeds in coronavirus treatment trial, company says medicine will prove helpful if given early
4 years, 8 months ago

Gilead's anti-viral drug Remdesivir succeeds in coronavirus treatment trial, company says medicine will prove helpful if given early

Firstpost  

Gilead Sciences Inc’s experimental antiviral drug remdesivir helped improve symptoms in COVID-19 patients who were given the drug early than among those who were treated later, the company said. Gilead Sciences Inc’s experimental antiviral drug Remdesivir helped improve symptoms in COVID-19 patients who were given the drug early than among those who were treated later, the company said. The closely-watched …

‘A drug can block coronavirus’: Gilead’s remdesivir raises hopes
4 years, 8 months ago

‘A drug can block coronavirus’: Gilead’s remdesivir raises hopes

Al Jazeera  

Top US scientist Anthony Fauci says the drug reduced the time it took for some patients to recover by 31 percent. The study, run by the US National Institutes of Health, tested remdesivir versus usual care in 1,063 hospitalised coronavirus patients around the world. At the White House, Dr Anthony Fauci, the director of the NIH’s National Institute of Allergy …

Clinical trial of remdesivir may be a turning point in coronavirus fight
4 years, 8 months ago

Clinical trial of remdesivir may be a turning point in coronavirus fight

LA Times  

Remdesivir, a drug developed to treat Ebola patients, is being tested as a treatment for patients infected with the new coronavirus. In the first clear signal that a drug can effectively treat those sickened by the coronavirus, government researchers reported Wednesday that the antiviral medication remdesivir helped patients with advanced COVID-19 recover more quickly than a placebo treatment. “Whenever you …

Remdesivir: Preliminary results from a trial could come in a week or two, researcher says
4 years, 8 months ago

Remdesivir: Preliminary results from a trial could come in a week or two, researcher says

CNN  

CNN — Preliminary results from a clinical trial of remdesivir, an experimental antiviral drug being tested for coronavirus, could come in as little as one to two weeks, a top researcher said Sunday. If the drug doesn’t work, we can remove the drug from the trial and try other therapies.” Leaked data and early results paint a confusing picture The …

Coronavirus UK: FTSE drops again as it slumps due to gloomy prospects for new drugs
4 years, 8 months ago

Coronavirus UK: FTSE drops again as it slumps due to gloomy prospects for new drugs

Daily Mail  

Stock markets fell today after a promising drug that experts hoped would become a breakthrough treatment for coronavirus flopped in its first key trial. Gilead also said that trends in the data suggest a potential benefit for remdesivir, 'particularly among patients treated early in disease'. Gilead is testing remdesivir in multiple trials, with results from a study involving 400 patients …

Gilead says Remdesivir trial posted online prematurely was ‘inconclusive’
4 years, 8 months ago

Gilead says Remdesivir trial posted online prematurely was ‘inconclusive’

CNN  

CNN — Results from a study investigating Gilead Sciences’ antiviral medication remdesivir as a Covid-19 treatment were posted to the World Health Organization’s website “prematurely” on Thursday and showed “inconclusive” results, according to the biotechnology company. “Today, information from the first clinical study evaluating the investigational antiviral remdesivir in patients with severe Covid-19 disease in China was prematurely posted on …

COVID-19 patients respond to Gilead's experimental drug remdesivir, says report
4 years, 8 months ago

COVID-19 patients respond to Gilead's experimental drug remdesivir, says report

India TV News  

Patients infected with the coronavirus are responding to remdesivir, an experimental drug of Gilead Sciences, news agency Reuters quoted a report as saying. Citing medical news website STAT, a University of Chicago hospital participating in a study of the antiviral medication said it is seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged from the hospital …

AI Uncovers a Potential Treatment for Covid-19 Patients
4 years, 8 months ago

AI Uncovers a Potential Treatment for Covid-19 Patients

Wired  

Late one January afternoon, British pharmacologist Peter Richardson ran out of his home office and told his wife, “Got it!” She asked what he was talking about and offered a cup of tea. Using the software, Richardson had identified a rheumatoid arthritis drug that might dampen some of the most severe effects of the new virus, an illness now known …

Remdesivir: Covid-19 patients recovering quickly after getting experimental drug
4 years, 8 months ago

Remdesivir: Covid-19 patients recovering quickly after getting experimental drug

CNN  

CNN — Covid-19 patients who are getting an experimental drug called remdesivir have been recovering quickly, with most going home in days, STAT News reported Thursday after it obtained a video of a conversation about the trial. We’ve only had two patients perish,” Dr. Kathleen Mullane, an infectious disease specialist at the University of Chicago who is leading the clinical …

Discover Related